BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17992093)

  • 1. Editorial: what is new in the treatment of gliomas?
    Omuro AM; Delattre JY
    Curr Opin Neurol; 2007 Dec; 20(6):704-7. PubMed ID: 17992093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
    Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Kyritsis AP; Levin VA
    Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
    Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
    Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in the treatment of malignant gliomas.
    Soffietti R; Leoncini B; Rudà R
    Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues.
    Dietrich J; Norden AD; Wen PY
    Curr Opin Neurol; 2008 Dec; 21(6):736-44. PubMed ID: 19060566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytotoxic drugs in the treatment of central nervous system gliomas.
    Neyns B; D'haeseleer M; Rogiers A; Van de Cauter J; Chaskis C; Michotte A; Strik H
    Acta Neurol Belg; 2010 Mar; 110(1):1-14. PubMed ID: 20514922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
    Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating molecular tools into clinical trials and treatment for gliomas?
    Lassman AB; Holland EC
    Curr Opin Neurol; 2007 Dec; 20(6):708-11. PubMed ID: 17992094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent high-grade gliomas.
    Wen PY; Brandes AA
    Curr Opin Neurol; 2009 Dec; 22(6):657-64. PubMed ID: 19770658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for low-grade gliomas: emerging consensus on its benefits.
    Wen PY; DeAngelis LM
    Neurology; 2007 May; 68(21):1762-3. PubMed ID: 17515537
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New chemotherapy options for the treatment of malignant gliomas.
    Soffietti R; Rudà R; Trevisan E
    Anticancer Drugs; 2007 Jul; 18(6):621-32. PubMed ID: 17762390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primetime for antiangiogenic therapy.
    Tabatabai G; Stupp R
    Curr Opin Neurol; 2009 Dec; 22(6):639-44. PubMed ID: 19786873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeted therapies and chemotherapy in malignant gliomas.
    Brandsma D; van den Bent MJ
    Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.